In another study, ovarian cancer [85] and NSCLC [94] patients with VM+/CD133+ tumors predicted a poor prognosis; VE-cadherin, MMP-2 and MMP-9 were also reported to be increased in CD133+ xenografted tumors [82]. The gene discussed is MMP2; the disease is non-small cell lung carcinoma.